We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
National Grid
NGG
$81.3B
| $18M | 0.01% |
377,408
+13,893
| +4% | +$836K |
|
1077
Unity
U
$18.9B
| $18M | 0.01% |
565,520
+32,549
| +6% | +$1.34M |
|
|
TMHC
1078
DELISTED
Taylor Morrison
TMHC
| $18M | 0.01% |
772,237
+310,999
| +67% | +$8.08M |
|
1079
Ryder
R
$10.1B
| $18M | 0.01% |
238,463
+46,013
| +24% | +$3.5M |
|
|
PGRE
1080
DELISTED
Paramount Group
PGRE
| $18M | 0.01% |
2,889,228
+73,580
| +3% | +$530K |
|
1081
Extreme Networks
EXTR
$3.15B
| $18M | 0.01% |
1,375,391
-465,678
| -25% | -$5.87M |
|
1082
Cirrus Logic
CRUS
$6.26B
| $17.9M | 0.01% |
260,382
-6,870
| -3% | -$540K |
|
|
TRTN
1083
DELISTED
Triton International Limited
TRTN
| $17.9M | 0.01% |
326,652
-88,217
| -21% | -$5.28M |
|
1084
Group 1 Automotive
GPI
$3.18B
| $17.8M | 0.01% |
124,646
-151
| -0.1% | -$25.9K |
|
1085
Enovix
ENVX
$1.03B
| $17.8M | 0.01% |
1,108,399
-170,691
| -13% | -$2.52M |
|
|
CSR
1086
Centerspace
CSR
$952M
| $17.8M | 0.01% |
264,072
+49,737
| +23% | +$3.95M |
|
1087
Stride
LRN
$3.43B
| $17.8M | 0.01% |
422,684
-174,657
| -29% | -$7.04M |
|
1088
Cabot Corp
CBT
$4.52B
| $17.8M | 0.01% |
277,922
-20,857
| -7% | -$1.47M |
|
|
CPRX
1089
DELISTED
Catalyst Pharmaceutical
CPRX
| $17.8M | 0.01% |
1,383,789
-65,968
| -5% | -$782K |
|
1090
Insmed
INSM
$28.6B
| $17.8M | 0.01% |
824,216
+342,694
| +71% | +$8.22M |
|
|
BHVN
1091
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $17.7M | 0.01% |
213,362
-7,333
| -3% | -$1.09M |
|
1092
Ironwood Pharmaceuticals
IRWD
$714M
| $17.7M | 0.01% |
1,711,399
-536,357
| -24% | -$6.08M |
|
1093
Children's Place
PLCE
$59.8M
| $17.7M | 0.01% |
572,159
-74,762
| -12% | -$3.14M |
|
1094
AGCO
AGCO
$7.2B
| $17.7M | 0.01% |
183,705
+9,640
| +6% | +$1M |
|
1095
Dave & Buster's
PLAY
$357M
| $17.6M | 0.01% |
568,658
+21,582
| +4% | +$807K |
|
|
NUVA
1096
DELISTED
NuVasive, Inc.
NUVA
| $17.6M | 0.01% |
402,268
-6,494
| -2% | -$315K |
|
|
SWCH
1097
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $17.6M | 0.01% |
522,294
+149,891
| +40% | +$5.08M |
|
1098
Bath & Body Works
BBWI
$4.1B
| $17.6M | 0.01% |
539,014
-6,181
| -1% | -$218K |
|
1099
Cytokinetics
CYTK
$10.4B
| $17.6M | 0.01% |
362,353
+1,344
| +0.4% | +$64.7K |
|
1100
NMI Holdings
NMIH
$3.36B
| $17.5M | 0.01% |
858,802
-56,671
| -6% | -$1.13M |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.